LIRAGLUTIDE ESCALATED TO 3.0 MG REDUCES HEPATIC STEATOSIS DURING 16 WEEKS' TREATMENT IN NON-DIABETIC OBESE PATIENTS
Gastroenterology(2020)
关键词
mg reduces hepatic steatosis,liraglutide,non-diabetic
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Gastroenterology(2020)